Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-17-021890
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-20 21:50:24
Reporting Period:
2017-03-16
Filing Date:
2017-03-20
Accepted Time:
2017-03-20 21:50:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1625101 Pulse Biosciences Inc. PLSE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1055919 W Robert Duggan 849 Mitten Road, Suite 104
Burlingame CA 94010
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-16 1,120 $22.54 2,174,479 No 4 P Direct
Common Stock Acquisiton 2017-03-16 69,162 $24.14 2,243,641 No 4 P Direct
Common Stock Acquisiton 2017-03-16 3,500 $24.93 2,247,141 No 4 P Direct
Common Stock Acquisiton 2017-03-17 25,859 $24.07 2,273,000 No 4 P Direct
Common Stock Acquisiton 2017-03-18 105,486 $23.01 2,378,486 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. This is the weighted average purchase price of the shares, which ranged from $22.45 to $23.248 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
  2. This is the weighted average purchase price of the shares, which ranged from $23.66 to $24.30 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
  3. This is the weighted average purchase price of the shares, which ranged from $24.89 to $24.96 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
  4. This is the weighted average purchase price of the shares, which ranged from $23.71 to $24.25 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
  5. This is the weighted average purchase price of the shares, which ranged from $22.40 to $23.30 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.